Jonathan Hurov
Company: Fog Pharma
Job title: Executive Vice President - Discovery Biology
Seminars:
Uncovering the Discovery of FOG-001, a First-And-Only-In-Class Direct B-Catenin Inhibiting Peptide 3:30 pm
day: Conference Day 1